MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression

Our findings suggest that miR-760 represents a potential onco-miR and participates in ovarian cancer carcinogenesis, which highlight its potential as a target for ovarian cancer therapy.